The DNA-binding domain mediates both nuclear and cytosolic functions of p53

Nature Structural and Molecular Biology

Volumn 21, Issue 6, 2014, Pages 535-543

  Follis, Ariele Viacava ^a   Llambi, Fabien ^a   Ou, Li ^a   Baran, Katherine ^a   Green, Douglas R ^a   Kriwacki, Richard W ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53; TETRAMER;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; MUTAGENESIS; NITROGEN NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET IRRADIATION; WILD TYPE;

APOPTOSIS; BCL-X PROTEIN; BINDING SITES; CELL NUCLEUS; CYTOSOL; HUMANS; MODELS, MOLECULAR; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84902009201     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2829     Document Type: Article

References (64)

1. Green, D.R. & Kroemer, G. Cytoplasmic functions of the tumour suppressor p53. Nature 458, 1127-1130 (2009).
2. Chipuk, J.E. et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014 (2004). (Pubitemid 38209704)
3. Leu, J.I., Dumont, P., Hafey, M., Murphy, M.E. & George, D.L. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 6, 443-450 (2004). (Pubitemid 38607505)
4. Chipuk, J.E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D.D. & Green, D.R. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309, 1732-1735 (2005). (Pubitemid 41285944)
5. Sattler, M. et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-986 (1997). (Pubitemid 27087715)
6. Petros, A.M. et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 9, 2528-2534 (2000). (Pubitemid 32105735)
7. Feng, W., Huang, S., Wu, H. & Zhang, M. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. J. Mol. Biol. 372, 223-235 (2007). (Pubitemid 47223231)
8. Liu, X., Dai, S., Zhu, Y., Marrack, P. & Kappler, J.W. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19, 341-352 (2003). (Pubitemid 37153411)
9. Cheng, E.H. et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705-711 (2001). (Pubitemid 32946946)
10. Kussie, P.H. et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953 (1996). (Pubitemid 26398409)
11. Wang, P. et al. p53 domains: structure, oligomerization, and transformation. Mol. Cell. Biol. 14, 5182-5191 (1994). (Pubitemid 24235946)
12. Petros, A.M., Gunasekera, A., Xu, N., Olejniczak, E.T. & Fesik, S.W. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR. FEBS Lett. 559, 171-174 (2004). (Pubitemid 38186723)
13. Sot, B., Freund, S.M. & Fersht, A.R. Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J. Biol. Chem. 282, 29193-29200 (2007). (Pubitemid 350043367)
14. Hagn, F. et al. BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J. Biol. Chem. 285, 3439-3450 (2010).
15. Yao, H. et al. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles. Biochemistry 52, 6324-6334 (2013).
16. Di Lello, P. et al. Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol. Cell 22, 731-740 (2006).
17. Lee, C.W., Martinez-Yamout, M.A., Dyson, H.J. & Wright, P.E. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein. Biochemistry 49, 9964-9971 (2010).
18. Xu, H., Tai, J., Ye, H., Kang, C.B. & Yoon, H.S. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl. Biochem. Biophys. Res. Commun. 341, 938-944 (2006). (Pubitemid 43221756)
19. Xu, H. et al. The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif. Biochemistry 48, 12159-12168 (2009).
20. Ha, J.H. et al. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways. J. Biol. Chem. 288, 7387-7398 (2013).
21. Livingstone, L.R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935 (1992).
22. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997). (Pubitemid 27152402)
23. Yonish-Rouach, E. et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347 (1991). (Pubitemid 21912356)
24. Mietz, J.A., Unger, T., Huibregtse, J.M. & Howley, P.M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11, 5013-5020 (1992). (Pubitemid 23023445)
25. Schultz, L.B., Chehab, N.H., Malikzay, A. & Halazonetis, T.D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151, 1381-1390 (2000). (Pubitemid 32047588)
26. Pervushin, K., Riek, R., Wider, G. & Wuthrich, K. Attenuated T-2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA 94, 12366-12371 (1997).
27. Muchmore, S.W. et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341 (1996).
28. Joerger, A.C., Allen, M.D. & Fersht, A.R. Crystal structure of a superstable mutant of human p53 core domain: insights into the mechanism of rescuing oncogenic mutations. J. Biol. Chem. 279, 1291-1296 (2004). (Pubitemid 38082653)
29. Follis, A.V. et al. PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis. Nat. Chem. Biol. 9, 163-168 (2013).
30. Galea, C., Bowman, P. & Kriwacki, R.W. Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils. Protein Sci. 14, 2993-3003 (2005). (Pubitemid 41770140)
31. Johnson, C.R., Morin, P.E., Arrowsmith, C.H. & Freire, E. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor-suppressor. Biochemistry 34, 5309-5316 (1995).
32. Kitayner, M. et al. Structural basis of DNA recognition by p53 tetramers. Mol. Cell 22, 741-753 (2006).
33. Cho, Y., Gorina, S., Jeffrey, P.D. & Pavletich, N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355 (1994). (Pubitemid 24259959)
34. Chipuk, J.E., Moldoveanu, T., Llambi, F., Parsons, M.J. & Green, D.R. The BCL-2 family reunion. Mol. Cell 37, 299-310 (2010).
35. Hollstein, M. et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555 (1994). (Pubitemid 24299821)
36. Hernandez-Boussard, T., Rodriguez-Tome, P., Montesano, R. & Hainaut, P. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. Hum. Mutat. 14, 1-8 (1999). (Pubitemid 29309938)
37. Bullock, A.N. et al. Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. USA 94, 14338-14342 (1997). (Pubitemid 28041374)
38. Inga, A. & Resnick, M.A. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants. Oncogene 20, 3409-3419 (2001). (Pubitemid 32588989)
39. Bullock, A.N., Henckel, J. & Fersht, A.R. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene 19, 1245-1256 (2000). (Pubitemid 30160617)
40. Kato, S. et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl. Acad. Sci. USA 100, 8424-8429 (2003). (Pubitemid 36842561)
41. Weinberg, R.L., Veprintsev, D.B. & Fersht, A.R. Cooperative binding of tetrameric p53 to DNA. J. Mol. Biol. 341, 1145-1159 (2004). (Pubitemid 39092307)
42. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49-53 (1991). (Pubitemid 21917115)
43. Joo, W.S. et al. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16, 583-593 (2002). (Pubitemid 34212491)
44. Gorina, S. & Pavletich, N.P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001-1005 (1996). (Pubitemid 26398426)
45. Lilyestrom, W., Klein, M.G., Zhang, R., Joachimiak, A. & Chen, X.S. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20, 2373-2382 (2006). (Pubitemid 44320386)
46. Kuwana, T. et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342 (2002). (Pubitemid 35341388)
47. Asciolla, J.J., Renault, T.T. & Chipuk, J.E. Examining BCL-2 family function with large unilamellar vesicles. J. Vis. Exp. doi:10.3791/4291(5 October 2012).
48. Llambi, F. et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol. Cell 44, 517-531 (2011).
49. Oltersdorf, T. et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677-681 (2005). (Pubitemid 40825512)
50. Liu, Y. & Bodmer, W.F. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc. Natl. Acad. Sci. USA 103, 976-981 (2006). (Pubitemid 43212207)
51. Jones, S. & Thornton, J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA 93, 13-20 (1996). (Pubitemid 26038096)
52. Miyashita, T. & Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
53. Wang, Y., Filippov, I., Richter, C., Luo, R. & Kriwacki, R.W. Solution NMR studies of an intrinsically unstructured protein within a dilute, 75 kDa eukaryotic protein assembly; probing the practical limits for efficiently assigning polypeptide backbone resonances. ChemBioChem 6, 2242-2246 (2005).
54. Bell, S., Hansen, S. & Buchner, J. Refolding and structural characterization of the human p53 tumor suppressor protein. Biophys. Chem. 96, 243-257 (2002). (Pubitemid 34548236)
55. Keller, R.J.J. Optimizing the process of nuclear magnetic resonance spectrum analysis and computer aided resonance assignment. PhD thesis, Eidgenossische Technishe Hochschule (2005).
56. Güntert, P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353-378 (2004).
57. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302 (1999). (Pubitemid 29143535)
58. Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein, R. & Thornton, J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486 (1996). (Pubitemid 126706801)
59. de Vries, S.J., van Dijk, M. & Bonvin, A.M. The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc. 5, 883-897 (2010).
60. Simon, B., Madl, T., Mackereth, C.D., Nilges, M. & Sattler, M. An efficient protocol for NMR-spectroscopy-based structure determination of protein complexes in solution. Angew. Chem. Int. Ed. Engl. 49, 1967-1970 (2010).
61. Wang, Y., Rosengarth, A. & Luecke, H. Structure of the human p53 core domain in the absence of DNA. Acta Crystallogr. D Biol. Crystallogr. 63, 276-281 (2007). (Pubitemid 46438519)
62. Reynolds, C., Damerell, D. & Jones, S. ProtorP: a protein-protein interaction analysis server. Bioinformatics 25, 413-414 (2009).
63. Saha, R.P., Bahadur, R.P., Pal, A., Mandal, S. & Chakrabarti, P. ProFace: a server for the analysis of the physicochemical features of protein-protein interfaces. BMC Struct. Biol. 6, 11 (2006).
64. Gabdoulline, R.R., Wade, R.C. & Walther, D. MolSurfer: a macromolecular interface navigator. Nucleic Acids Res. 31, 3349-3351 (2003). (Pubitemid 37442156)